# TG THERAPEUTICS, INC. (TGTX) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from TG THERAPEUTICS, INC.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/TGTX/mda/fy2025/): filed 2026-02-27; accession 0001437749-26-006133 (https://www.sec.gov/Archives/edgar/data/1001316/000143774926006133/tgtx20251231_10k.htm); latest 10-K
- [FY 2024 MD&A](/company/TGTX/mda/fy2024/): filed 2025-03-03; accession 0001437749-25-005908 (https://www.sec.gov/Archives/edgar/data/1001316/000143774925005908/tgtx20241231_10k.htm)
- [FY 2023 MD&A](/company/TGTX/mda/fy2023/): filed 2024-02-29; accession 0001437749-24-006144 (https://www.sec.gov/Archives/edgar/data/1001316/000143774924006144/tgtx20231231_10k.htm)
- [FY 2022 MD&A](/company/TGTX/mda/fy2022/): filed 2023-03-01; accession 0001558370-23-002610 (https://www.sec.gov/Archives/edgar/data/1001316/000155837023002610/tgtx-20221231x10k.htm)
- [FY 2021 MD&A](/company/TGTX/mda/fy2021/): filed 2022-03-01; accession 0001558370-22-002617 (https://www.sec.gov/Archives/edgar/data/1001316/000155837022002617/tgtx-20211231x10k.htm)

Back to /company/TGTX/